FDA Inspection 1227751 — Anthony Chan, M.D.
The FDA completed an inspection of Anthony Chan, M.D. on Jan 11, 2024 in West Hamilton. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 11, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- West Hamilton (Canada)
Additional details
Clinical Investigator (CI)